QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, September 20, 2006, 26(38):9750-9760; doi:10.1523/JNEUROSCI.2745-06.2006

This Article Full Text Full Text (PDF) Supplemental data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in J. Neurosci. Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Murase, S. Articles by McKay, R. D. Search for Related Content PubMed PubMed Citation Articles by Murase, S. Articles by McKay, R. D.

 Previous Article  |  Next Article 

Neurobiology of Disease
A Specific Survival Response in Dopamine Neurons at Most Risk in Parkinson's Disease

Sachiko Murase and Ronald D. McKay

Laboratory of Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892

Correspondence should be addressed to Ronald D. McKay, 35 Convent Drive, MSC 4092, Bethesda, MD 20892. Email: mckay{at}codon.nih.gov

The specific expression of fibroblast growth factor 20 (FGF-20) in the adult substantia nigra and the association between FGF-20 mutations and Parkinson's disease provoked exploration of the function of this growth factor. We show by gain- and loss-of-function in vitro experiments that FGF-20 promotes survival and stimulates dopamine (DA) release in a calbindin-negative subset of cells that are preferentially lost in Parkinson's disease. FGF-20 selectively activates tyrosine hydroxylase in calbindin-negative neurons. In the adult substantia nigra, calbindin-negative neurons specifically express high levels of FGFR1 (FGF receptor 1). These data show that FGF signals to elevate DA levels and protect the specific midbrain neuron type at most risk in Parkinson's patients.

Key words: Parkinson's disease; fibroblast growth factor 20; dopamine; calbindin; midbrain; neurotrophic factor

---

Received Feb. 7, 2006; revised Aug. 8, 2006; accepted Aug. 10, 2006.

Correspondence should be addressed to Ronald D. McKay, 35 Convent Drive, MSC 4092, Bethesda, MD 20892. Email: mckay{at}codon.nih.gov

Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2006 26: i. [Full Text]  

This article has been cited by other articles:

				A. Androutsellis-Theotokis, M.A. Rueger, H. Mkhikian, E. Korb, and R.D.G. McKay Signaling Pathways Controlling Neural Stem Cells Slow Progressive Brain Disease Cold Spring Harb Symp Quant Biol, November 6, 2008; (2008) sqb.2008.73.018v1. [Abstract] [PDF]

				R. Sanchez-Pernaute, H. Lee, M. Patterson, C. Reske-Nielsen, T. Yoshizaki, K. C. Sonntag, L. Studer, and O. Isacson Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease Brain, August 1, 2008; 131(8): 2127 - 2139. [Abstract] [Full Text] [PDF]

				K. A. Trzaska, E. V. Kuzhikandathil, and P. Rameshwar Specification of a Dopaminergic Phenotype from Adult Human Mesenchymal Stem Cells Stem Cells, November 1, 2007; 25(11): 2797 - 2808. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help